| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets
|
Mottini, Carla
|
|
|
68 |
C |
p. 59-74
|
article
|
| 2 |
Current progress and future perspectives of polypharmacology : From the view of non-small cell lung cancer
|
Karuppasamy, Ramanathan
|
|
|
68 |
C |
p. 84-91
|
article
|
| 3 |
Current state and future perspective of drug repurposing in malignant glioma
|
Siegelin, Markus David
|
|
|
68 |
C |
p. 92-104
|
article
|
| 4 |
Drug rechanneling: A novel paradigm for cancer treatment
|
Kaushik, Itishree
|
|
|
68 |
C |
p. 279-290
|
article
|
| 5 |
Drug repurposing for breast cancer therapy: Old weapon for new battle
|
Aggarwal, Sadhna
|
|
|
68 |
C |
p. 8-20
|
article
|
| 6 |
Drug repurposing for cancer therapy, easier said than done
|
Gonzalez-Fierro, Aurora
|
|
|
68 |
C |
p. 123-131
|
article
|
| 7 |
Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - A missed opportunity
|
Perez, Dominique R.
|
|
|
68 |
C |
p. 199-208
|
article
|
| 8 |
Editorial Board
|
|
|
|
68 |
C |
p. ii
|
article
|
| 9 |
Machine and deep learning approaches for cancer drug repurposing
|
Issa, Naiem T.
|
|
|
68 |
C |
p. 132-142
|
article
|
| 10 |
Old drugs, new uses: Drug repurposing in hematological malignancies
|
Kale, Vijay P.
|
|
|
68 |
C |
p. 242-248
|
article
|
| 11 |
Phyotochemical candidates repurposing for cancer therapy and their molecular mechanisms
|
Jung, Ji Hoon
|
|
|
68 |
C |
p. 164-174
|
article
|
| 12 |
Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs
|
Sohraby, Farzin
|
|
|
68 |
C |
p. 249-257
|
article
|
| 13 |
Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment
|
La-Beck, Ninh M.
|
|
|
68 |
C |
p. 175-185
|
article
|
| 14 |
Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy
|
Shaw, Vikram
|
|
|
68 |
C |
p. 75-83
|
article
|
| 15 |
Repurposing drugs in oncology: From candidate selection to clinical adoption
|
Pantziarka, Pan
|
|
|
68 |
C |
p. 186-191
|
article
|
| 16 |
Repurposing of artemisinin-type drugs for the treatment of acute leukemia
|
Lu, Xiaohua
|
|
|
68 |
C |
p. 291-312
|
article
|
| 17 |
Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics
|
Kirtonia, Anuradha
|
|
|
68 |
C |
p. 258-278
|
article
|
| 18 |
Repurposing of drugs as STAT3 inhibitors for cancer therapy
|
Thilakasiri, Pathum S.
|
|
|
68 |
C |
p. 31-46
|
article
|
| 19 |
Repurposing of plant alkaloids for cancer therapy: Pharmacology and toxicology
|
Efferth, Thomas
|
|
|
68 |
C |
p. 143-163
|
article
|
| 20 |
Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment
|
Yang, Huanjie
|
|
|
68 |
C |
p. 105-122
|
article
|
| 21 |
Repurposing quinacrine for treatment-refractory cancer
|
Oien, Derek B.
|
|
|
68 |
C |
p. 21-30
|
article
|
| 22 |
Small-molecule drug repurposing to target DNA damage repair and response pathways
|
Brinkman, Jacqueline A.
|
|
|
68 |
C |
p. 230-241
|
article
|
| 23 |
Special issue: Drug repurposing for cancer therapy
|
Srivastava, Sanjay K.
|
|
|
68 |
C |
p. 1-2
|
article
|
| 24 |
Structure-based drug repositioning: Potential and limits
|
Adasme, Melissa F.
|
|
|
68 |
C |
p. 192-198
|
article
|
| 25 |
Systems biology based drug repositioning for development of cancer therapy
|
Turanli, Beste
|
|
|
68 |
C |
p. 47-58
|
article
|
| 26 |
Turning liabilities into opportunities: Off-target based drug repurposing in cancer
|
Palve, Vinayak
|
|
|
68 |
C |
p. 209-229
|
article
|
| 27 |
What patents tell us about drug repurposing for cancer: A landscape analysis
|
Mucke, Hermann A.M.
|
|
|
68 |
C |
p. 3-7
|
article
|
Journal description